BNF:

7.4.1

Status:

Do Not Prescribe (DNP), Grey

Decision Date:

December 2018

Comments

GREY: To be used if the combination is required and compliance is an issue for the patient. Cost effective to prescribe generically. 

Do Not Prescribe (DNP): the brand Combodart is significantly more expensive than the individual components of dutasteride and tamsulosin or the generic combination capsule

 

Do Not Prescribe (DNP) Drug Classifications

• 5: Less cost-effective than current standard therapy

search again